drugset / Trial / NCT01668511
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the Knee
RandomizedParallel-groupTriple-blindTreatment
Summary
To assess the safety, tolerability and pharmacokinetics of ABT-981 in patients with osteoarthritis of the knee.
Timeline
- Start
- 2012-09
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lutikizumab | Monoclonal antibody | 0.3 mg/kg | Subcutaneous |
| Subject | Lutikizumab | Monoclonal antibody | 1 mg/kg | Subcutaneous |
| Subject | Lutikizumab | Monoclonal antibody | 3 mg/kg | Subcutaneous |